Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:08
Cumberland Pharmaceuticals Price to Book Value : 5.688 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.688 |
| September 04, 2026 | 5.834 |
| September 03, 2026 | 5.800 |
| September 02, 2026 | 5.602 |
| September 01, 2026 | 5.636 |
| August 31, 2026 | 5.748 |
| August 28, 2026 | 7.269 |
| August 27, 2026 | 7.432 |
| August 26, 2026 | 7.707 |
| August 25, 2026 | 7.475 |
| August 24, 2026 | 6.736 |
| August 21, 2026 | 6.573 |
| August 20, 2026 | 6.444 |
| August 19, 2026 | 6.573 |
| August 18, 2026 | 6.556 |
| August 17, 2026 | 6.599 |
| August 14, 2026 | 6.693 |
| August 13, 2026 | 6.788 |
| August 12, 2026 | 6.796 |
| August 11, 2026 | 6.839 |
| August 10, 2026 | 6.693 |
| August 07, 2026 | 6.702 |
| August 06, 2026 | 6.599 |
| August 05, 2026 | 6.487 |
| August 04, 2026 | 6.676 |
| Date | Value |
|---|---|
| August 03, 2026 | 6.169 |
| July 31, 2026 | 5.740 |
| July 30, 2026 | 5.783 |
| July 29, 2026 | 5.722 |
| July 28, 2026 | 5.851 |
| July 27, 2026 | 6.040 |
| July 24, 2026 | 5.680 |
| July 23, 2026 | 6.002 |
| July 22, 2026 | 6.113 |
| July 21, 2026 | 6.745 |
| July 20, 2026 | 6.272 |
| July 17, 2026 | 5.877 |
| July 16, 2026 | 6.582 |
| July 15, 2026 | 6.702 |
| July 14, 2026 | 6.002 |
| July 13, 2026 | 5.619 |
| July 10, 2026 | 5.095 |
| July 09, 2026 | 5.190 |
| July 08, 2026 | 5.370 |
| July 07, 2026 | 5.404 |
| July 06, 2026 | 5.293 |
| July 02, 2026 | 5.473 |
| July 01, 2026 | 6.126 |
| June 30, 2026 | 5.568 |
| June 29, 2026 | 4.737 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.627 |
| Eli Lilly & Co. | 31.23 |
| ANI Pharmaceuticals, Inc. | 2.702 |
| Corcept Therapeutics, Inc. | 17.43 |
| Veru, Inc. | 1.550 |
Price to Book Value Related Metrics
| PS Ratio | 3.168 |
| PEG Ratio | -0.0375 |
| Price to Free Cash Flow | 158.76 |
| Price | 6.62 |
| Earnings Yield | -11.02% |
| Market Cap | 99.19M |
| PEGY Ratio | -0.0375 |